A Comparison of the Prevalence of the Metabolic Syndrome among Sri Lankan Patients with Type 2 Diabetes Mellitus Using WHO, NCEP-ATP III, and IDF Definitions
Table 5
General characteristics of the subjects with metabolic syndrome according to the three definitions.
Variables
IDF
WHO
NCEP-ATP III
Mean
SD
Mean
SD
Mean
SD
Duration of diabetes in years
5.5
5.90
5.1
5.74
5.1
5.44
Age in years
47.6
78.63
46.1
62.29
47.3
68.81
Waist circumference (cm)
94.4
7.59
93.0#
8.89
94.4
10.09
Body mass index (kg/m2)
25.8
3.94
25.2#
4.16
26.0
4.64
Systolic blood pressure (mmHg)
131.4†
17.00
128.4#
17.00
133.6
16.76
Diastolic blood pressure (mmHg)
80.8†
9.63
79.7#
9.17
81.8
9.41
(%)
7.3
1.06
7.3
0.99
7.3
1.16
Total cholesterol (mg/dL)
201.6
42.05
200.3
40.19
201.6
42.43
LDL cholesterol (mg/dL
124.6
39.16
123.8
36.81
123.9
38.92
HDL cholesterol (mg/dL)
49.0†
9.49
49.9#
8.97
48.1
9.98
P< 0.05 compared to WHO criteria. † p < 0.05 compared to NCEP-ATP III criteria. p < 0.05 compared to NCEP-ATP III criteria.
